CD Biosynsis offers high-quality Pichia pastoris Protein Expression and Purification Services, utilizing this methylotrophic yeast chassis for the reliable and scalable production of complex recombinant proteins. Pichia pastoris (Komagataella phaffii) is the industry gold standard eukaryotic host, particularly suited for expressing proteins that require post-translational modifications (PTMs), disulfide bond formation, and high-level extracellular secretion, which are challenging for bacterial systems. Our comprehensive service spans from gene design (including codon optimization for Pichia) and vector construction to high-cell-density fermentation and multi-step chromatography for high-purity protein isolation. We specialize in producing functional, correctly folded proteins such as secreted therapeutic proteins, complex enzymes, and vaccine antigens, ensuring clients receive high-quality material for structural biology, drug screening, and diagnostics.
Get a QuoteThe key advantage of using Pichia pastoris over prokaryotic hosts is its intrinsic eukaryotic machinery. This includes the endoplasmic reticulum (ER) and Golgi apparatus, which are essential for processing, folding, and secreting proteins that require disulfide bridges, native folding, or other PTMs for functionality. Our platform leverages optimized yeast expression vectors, particularly those utilizing the strong AOX1 promoter for tight, inducible control, tailored High-Cell-Density Culture (HCDC) protocols, and efficient secretion systems to maximize soluble, active protein yield. This focus on eukaryotic fidelity ensures the final purified protein closely matches its native structure and function.
Codon Optimization
Rational design and optimization of the target gene sequence to match the Pichia pastoris codon usage, enhancing translation efficiency and yield in the eukaryotic ribosomes.
Inducible Promoter Systems
Use of specialized, tightly regulated promoters (e.g., strong AOX1 or constitutive GAP) to control protein expression, optimizing induction timing and preventing misfolding or toxicity.
Secretion Optimization
Integration of optimal signal peptides (e.g., $\alpha$-factor) to efficiently route the protein through the ER/Golgi apparatus for extracellular secretion, simplifying downstream purification.
Affinity Chromatography (AC)
Primary capture using tags (His-tag, FLAG) or direct capture of secreted proteins from the culture supernatant, drastically reducing the initial cell lysis steps.
Ion Exchange Chromatography (IEX)
Used as a polishing step to remove residual host cell proteins (HCPs), including native proteases, and improve purity based on the target protein's charge properties.
Size Exclusion Chromatography (SEC)
Final polishing step used to achieve monomeric purity (>95%) and verify the protein's native oligomeric state and structural integrity.
Therapeutic/Complex Proteins
Expression of large, multi-domain proteins, antibody fragments (e.g., Fab), or cytokines that require disulfide bond formation characteristic of the Pichia pastoris ER.
Glycosylation-Sensitive Proteins
Production of proteins that require N-linked glycosylation, leveraging Pichia's simpler glycan structure compared to S. cerevisiae, with options for humanized glycan engineering.
Functional Enzymes
High-yield production of complex metabolic enzymes or secreted industrial enzymes, ensuring native folding and maximum activity.
A systematic process from gene synthesis to final quality-controlled protein.
1. Design & Vector Construction
2. High-Density Expression & Integration
3. Multi-Step Purification
4. QC & Final Delivery
Codon optimize gene for Pichia pastoris; design purification tags and secretion signal.
Clone gene into optimized yeast expression vector (e.g., pPICZ) or integrate into the chromosome via CRISPR-Cas9.
Transform the host strain using high-efficiency Pichia transformation protocols.
Establish small-scale culture conditions to test expression, solubility, and secretion efficiency.
Scale up production using customized High-Cell-Density Culture (HCDC) media and methanol-based or glucose-based fermentation protocols.
Induce expression at optimal cell density and harvest culture/supernatant.
Purity analysis via SDS-PAGE (>95% guaranteed) and Western Blot for identity.
Functional analysis (e.g., enzyme activity, binding kinetics) and PTM analysis upon request.
Delivery of purified protein, QC report, and documentation of expression and purification protocols.
High Volumetric Yield
The host's ability to achieve ultra-high cell densities (HCDC) and utilize the strong AOX1 promoter allows for the highest reported volumetric protein yields among yeast expression systems.
High Secretion & Purity
Efficiently secretes proteins into the medium with low native protein contamination, dramatically simplifying purification and achieving higher final product purity.
Correct Eukaryotic Folding
Provides the necessary ER/Golgi machinery for correct disulfide bond formation and folding of complex, multi-domain proteins, unlike bacterial systems.
Genetic Stability
Preference for chromosomal integration (often multi-copy) ensures high expression stability over long fermentation runs, essential for industrial scale-up.
1. Why is Pichia pastoris the industry standard for high-yield expression?
Pichia excels due to the combination of the ultra-strong, inducible AOX1 promoter and its ability to grow to extremely high cell densities (HCDC), leading to unmatched volumetric productivity.
2. Can the system handle proteins that require disulfide bonds?
Yes. The yeast's oxidizing environment in the ER and its chaperone network are highly efficient at promoting the correct formation of disulfide bonds, which are critical for the activity and structure of many therapeutic proteins.
3. Do you offer services for humanized glycosylation?
Yes. Wild-type Pichia has simpler glycan structures than S. cerevisiae. We offer services using engineered Pichia strains that have been modified (glycoengineered) to produce human-like N-glycans, suitable for biopharmaceuticals.
4. How is the protein purified if it is secreted?
If the protein is secreted (using a signal peptide), the cell biomass is removed, and the culture supernatant is subjected directly to multi-step chromatography (Affinity, IEX, SEC), significantly streamlining purification.
5. What is the role of Codon Optimization for a Pichia project?
Codon optimization ensures that the gene sequence matches the preferred codon usage of Pichia pastoris, minimizing translational pauses and maximizing the rate and efficiency of protein synthesis by the yeast ribosomes.
6. Do you use the methanol-inducible AOX1 promoter or constitutive promoters?
We offer both. The AOX1 promoter is used for maximum titer via methanol induction. We also use constitutive promoters (like GAP) for methanol-free fermentation, or we use CRISPR-Cas9 to swap promoters based on client requirements.
7. How do you prevent the degradation of secreted proteins?
We use protease-deficient host strains (where native proteases like PEP4 and KEX1 have been knocked out) to minimize the degradation of high-value secreted proteins during fermentation and downstream processing.
8. What is the difference between plasmid-based and chromosomal expression?
Chromosomal integration (our preference) ensures stable, permanent expression with consistent gene dosage, essential for scale-up. Plasmid-based expression is faster but risks plasmid loss and copy number variation over time.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.